Study guide

12.2 Active Management of the Third Stage of Labor & PPH

Clinical Officers Council Pre-Internship Examination Kenya

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Overview & Exam Strategy

1.1 About the COC Pre-Internship Examination 1.2 Clinical Decision-Making & Preparation Strategy

2 Chapter 2: Infectious & Communicable Diseases (Internal Medicine)

2.1 Malaria Diagnosis & Case Management 2.2 Tuberculosis & Leprosy Control 2.3 HIV/AIDS & Opportunistic Infections 2.4 Enteric & Neglected Tropical Infections

3 Chapter 3: Cardiovascular & Respiratory Medicine (Internal Medicine)

3.1 Hypertension & Cardiovascular Disorders 3.2 Respiratory Disorders & Acute Emergencies 3.3 Venous Thromboembolism & Vascular Emergencies

4 Chapter 4: Metabolic, Gastrointestinal & Neurological Medicine (Internal Medicine)

4.1 Diabetes Mellitus & Endocrine Emergencies 4.2 Gastrointestinal & Hepatorenal Disorders 4.3 Neurological Emergencies & Acute Toxicology

5 Chapter 5: Trauma Resuscitation & Emergency Surgery (General Surgery)

5.1 ATLS Primary Survey & Trauma Resuscitation 5.2 Burn Assessment & Fluid Resuscitation 5.3 Surgical Wounds, Infections & Tetanus Prophylaxis

6 Chapter 6: Acute Abdomen & Gastrointestinal Surgery (General Surgery)

6.1 Acute Appendicitis & Peritonitis 6.2 Intestinal Obstruction & Abdominal Hernias 6.3 Hepatobiliary, Pancreatic & Anorectal Surgical Conditions

7 Chapter 7: Orthopedics, Urology & Special Surgical Emergencies (General Surgery)

7.1 Fractures, Dislocations & Cast Management 7.2 Acute Compartment Syndrome & Limb Emergencies 7.3 Urological Emergencies & Pelvic Trauma 7.4 Emergency Airway, Anesthesia & Oncology Screening

8 Chapter 8: Essential Newborn Care & Neonatal Conditions (Pediatrics)

8.1 Immediate Newborn Care & Neonatal Resuscitation 8.2 Neonatal Jaundice, Sepsis & Common Disorders 8.3 Low Birth Weight & Kangaroo Mother Care

9 Chapter 9: IMCI Guidelines & Common Pediatric Conditions (Pediatrics)

9.1 IMCI Principles & General Danger Signs 9.2 Cough, Fast Breathing & Pediatric Pneumonia 9.3 Pediatric Diarrheal Diseases & Dehydration 9.4 Acute Pediatric Infections: Meningitis, Croup & Febrile Seizures

10 Chapter 10: Child Nutrition, KEPI & Preventive Pediatrics (Pediatrics)

10.1 Severe Acute Malnutrition (SAM) Management 10.2 KEPI Immunization Schedule & Vaccine Logistics 10.3 Pediatric Prophylaxis & Early Infant Diagnosis

11 Chapter 11: Antenatal Care & Medical Complications of Pregnancy (Obstetrics & Gynecology)

11.1 Focused Antenatal Care & Routine ANC Screening 11.2 Hypertensive Disorders of Pregnancy & Eclampsia 11.3 Medical Disorders & Infections in Pregnancy

12 Chapter 12: Labor, Delivery & Obstetric Emergencies (Obstetrics & Gynecology)

12.1 Normal Labor & Partograph Monitoring 12.2 Active Management of the Third Stage of Labor & PPH 12.3 Antepartum Hemorrhage & Uterine Rupture 12.4 Induction of Labor & Malpresentation Emergencies

13 Chapter 13: Puerperium, Gynecological Disorders & Family Planning (Obstetrics & Gynecology)

13.1 Puerperal Sepsis & Postnatal Complications 13.2 Pelvic Inflammatory Disease & Gynecological Conditions 13.3 Modern Contraceptive Technology & WHO MEC Criteria

14 Chapter 14: Primary Health Care & Devolved Health Systems (Community Health)

14.1 Primary Health Care Principles & Universal Health Coverage 14.2 Kenya Health Service Delivery Structure & Devolved Governance 14.3 Kenya Community Health Strategy & Level 1 Services

15 Chapter 15: Epidemiology, Disease Surveillance & Outbreak Response (Community Health)

15.1 Epidemiological Principles & Health Indicators 15.2 Integrated Disease Surveillance and Response (IDSR) 15.3 Vector Control & Neglected Tropical Diseases

16 Chapter 16: Environmental Health, Waste Management & Cold Chain (Community Health)

16.1 Water Quality & Household Water Treatment 16.2 Community Sanitation & Excreta Disposal 16.3 Healthcare Waste Management & Infection Prevention Control 16.4 Vaccine Cold Chain Management & Quality Monitoring

17 Chapter 17: Health Systems Management — Leadership, Policy & Financing

17.1 Management Functions, Leadership & Supportive Supervision 17.2 Kenya Health Policy, Planning & the Devolved Budget Cycle 17.3 Health Financing & Universal Health Coverage under the Social Health Authority 17.4 Human Resource Management, Scheme of Service & Performance Appraisal

18 Chapter 18: Health Commodities, Information & Quality Management

18.1 Health Commodity & Supply Chain Management (KEMSA) 18.2 Health Information Systems, Records & KHIS Reporting 18.3 Quality Improvement, Clinical Audit & Patient Safety

19 Chapter 19: Professional Practice, Ethics & Medico-Legal Responsibility

19.1 Scope of Practice, Registration, Licensing & Professional Discipline 19.2 Medical Ethics, Informed Consent & Patient Rights 19.3 Medico-Legal Documentation, Statutory Notification & Facility Safety Governance

12.2 Active Management of the Third Stage of Labor & PPH

Key Takeaways Explain This Topic AI

Active Management of the Third Stage of Labor (AMTSL) reduces postpartum hemorrhage incidence by up to 60-70% and comprises three core steps: uterotonic administration within 1 minute of fetal delivery, controlled cord traction (Brandt-Andrews maneuver), and immediate fundal massage.

Oxytocin 10 IU IM is the preferred first-line uterotonic; Ergometrine 0.2 mg IM is an alternative but is strictly contraindicated in pre-eclampsia, eclampsia, and chronic hypertension.

Postpartum Hemorrhage (PPH) is defined as cumulative blood loss >= 500 mL following vaginal delivery, >= 1,000 mL following Cesarean delivery, or any bleeding causing hemodynamic compromise.

The underlying causes of PPH follow the '4 Ts' framework: Tone (uterine atony, 70-80%), Trauma (lacerations/rupture, 20%), Tissue (retained placenta/membranes, 10%), and Thrombin (coagulopathies/DIC, 1%).

Emergency PPH medical management requires high-dose oxytocin infusion, IV Tranexamic Acid (1 g within 3 hours), Ergometrine, and sublingual/rectal Misoprostol; refractory atony warrants low-cost condom-catheter Uterine Balloon Tamponade (UBT) prior to surgical B-Lynch sutures or hysterectomy.

Last updated: September 2026

12.2 Active Management of the Third Stage of Labor & PPH

Core Obstetric Emergency Principle: Postpartum hemorrhage (PPH) is the leading direct cause of maternal mortality in Kenya. In severe PPH, a parturient can exsanguinate in less than 30 minutes. Active Management of the Third Stage of Labor (AMTSL) must be practiced routinely for every single delivery, and the '4 Ts' algorithm must be executed systematically without delay the moment blood loss exceeds normal parameters.

The third stage of labor begins immediately after the delivery of the neonate and ends with the complete expulsion of the placenta and fetal membranes. Placental separation is achieved by strong myometrial contractions that dramatically reduce the surface area of the placental implantation site, shearing the placenta away from the decidua basalis. Once separated, sustained myometrial retraction compresses the tortuous maternal spiral arteries—a physiological phenomenon termed 'living ligatures'. When myometrial retraction fails, rapid and fatal hemorrhage ensues.

1. The Three Core Steps of AMTSL

AMTSL is an evidence-based clinical package that significantly reduces the incidence of primary PPH by accelerating placental delivery and optimizing myometrial tone: +---------------------------------------------------------------------------------------------------------+

  • | ACTIVE MANAGEMENT OF THE THIRD STAGE OF LABOR (AMTSL) |
  • +---+---------------------------+-------------------------------------------------------------------------+
  • | # | STEP | CLINICAL PROTOCOL & TECHNIQUE |
  • +---+---------------------------+-------------------------------------------------------------------------+
  • | 1 | Uterotonic Administration | Administer Oxytocin 10 IU IM within 1 minute of fetal delivery. |
  • | | | MANDATORY: Palpate maternal abdomen FIRST to rule out undiagnosed twin!|
  • | | | Alternative: Misoprostol 400–600 mcg orally or Ergometrine 0.2 mg IM. |
  • +---+---------------------------+-------------------------------------------------------------------------+
  • | 2 | Controlled Cord Traction | Brandt-Andrews Maneuver: |
  • | | (CCT) | • Clamp cord close to perineum when pulsations cease. |
  • | | | • Wait for a strong uterine contraction (globular, firm fundus). |
  • | | | • Apply gentle, steady downward cord traction with right hand. |
  • | | | • Concurrently push lower uterine segment UP & BACK with left hand |
  • | | | placed suprapubically (counter-traction). |
  • | | | • Gently twist placenta 360° upon exit to tease out intact membranes. |
  • | | | • STRICT RULE: Never pull without counter-traction or on relaxed uterus!|
  • +---+---------------------------+-------------------------------------------------------------------------+
  • | 3 | Uterine Fundal Massage | • Immediately massage the uterine fundus vigorously through the |
  • | | | anterior abdominal wall until firm and contracted ('cricket ball'). |
  • | | | • Inspect placenta and membranes for completeness (cotyledons intact). |
  • | | | • Repeat fundal palpation & massage every 15 minutes for 2 hours. |
  • | | | • Teach the mother to palpate her own fundus to ensure persistent tone. |
  • +---+---------------------------+-------------------------------------------------------------------------+
  • Uterotonic Agents: Characteristics & Contraindications

Oxytocin (First-Line Gold Standard): Dose: 10 IU Intramuscularly (IM) . Mechanism: Activates G-protein coupled oxytocin receptors, causing rhythmic and sustained myometrial contractions. Onset: 2 to 3 minutes IM. Advantages: No hypertensive adverse effects; safe in pre-eclampsia, cardiac disease, and asthma. Requires cold chain storage (2°C to 8°C).

Ergometrine / Methylergometrine: Dose: 0.2 mg IM . Mechanism: Ergot alkaloid producing prolonged, tetanic uterine smooth muscle spasms. Onset: 2 to 5 minutes IM. STRICT CONTRAINDICATION: Strictly contraindicated in gestational hypertension, pre-eclampsia, eclampsia, chronic hypertension, and cardiac disease due to potent peripheral vasoconstriction triggering acute hypertensive crisis, stroke, and pulmonary edema.

Misoprostol: Dose: 400 to 600 mcg orally or sublingually . Mechanism: Synthetic prostaglandin E1 (PGE1) analogue. Excellent stability at room temperature (ideal for peripheral dispensaries without cold chain). Common side effects: Shivering, rigors, transient pyrexia (up to 40°C), and diarrhea.

2. Postpartum Hemorrhage: Definition and Classification

Clinical Definition: Blood loss of >= 500 mL following vaginal delivery, >= 1,000 mL following Cesarean delivery, or any volume of blood loss that causes signs of hemodynamic instability (tachycardia, tachypnea, hypotension, pallor, cold extremities, oliguria, or confusion).

Primary PPH: Hemorrhage occurring within the first 24 hours after delivery. Accounts for over 90% of all PPH cases and the vast majority of maternal fatalities.

Secondary PPH: Hemorrhage occurring between 24 hours and 6 weeks postpartum . Most commonly caused by retained placental fragments/cotyledons, secondary infection (endometritis), or delayed subinvolution of the placental site.

3. Etiological Stratification: The '4 Ts' Framework

Whenever PPH is suspected or diagnosed, the clinician must systematically investigate the '4 Ts': +---------------------------------------------------------------------------------------------------------+

  • | THE '4 Ts' ETIOLOGY OF PPH |
  • +----------+------------+-----------------------------------+---------------------------------------------+
  • | 'T' TYPE | FREQUENCY | UNDERLYING PATHOLOGY & RISKS | HALLMARK CLINICAL FINDINGS |
  • +----------+------------+-----------------------------------+---------------------------------------------+
  • | TONE | 70% to 80% | Uterine Atony (failure of | • Soft, flaccid, 'boggy' uterine fundus |
  • | | | myometrium to contract & retract).| • Fundus elevated above umbilicus |
  • | | | Risks: multiparity, polyhydramnios| • Massive dark blood and clots gush out |
  • | | | twins, prolonged/precipitous labor| upon abdominal massage |
  • +----------+------------+-----------------------------------+---------------------------------------------+
  • | TRAUMA | ~20% | Lacerations of perineum, vagina, | • Uterus is ROCK-HARD and FIRMLY CONTRACTED |
  • | | | cervix, or lower uterine segment; | • Persistent continuous trickling or spurting|
  • | | | uterine rupture; inverted uterus | of bright red arterial blood |
  • +----------+------------+-----------------------------------+---------------------------------------------+
  • | TISSUE | ~10% | Retained succenturiate lobe, | • Incomplete placenta or missing cotyledons |
  • | | | retained cotyledons/membranes, | • Uterus remains persistently subinvoluted |
  • | | | morbidly adherent placenta accreta| • Continued intermittent atony and bleeding |
  • +----------+------------+-----------------------------------+---------------------------------------------+
  • | THROMBIN | ~1% | Pre-existing coagulopathies, DIC | • Blood fails to form clots in dry tube |
  • | | | secondary to severe abruption, | • Oozing from IV puncture sites, gums, |
  • | | | eclampsia, or amniotic embolism | hematuria, petechiae |
  • +----------+------------+-----------------------------------+---------------------------------------------+
  • 4. Emergency Stepwise PPH Resuscitation Protocol [DIAGNOSIS OF POSTPARTUM HEMORRHAGE]
  • (Blood Loss >= 500 mL or Shock)
  • │
  • ▼
  • [ACTIVATE CODE RED / OBSTETRIC EMERGENCY CALL FOR HELP]
  • (Midwife, Clinical Officer, Nurse, Anesthetist)
  • │
  • ┌──────────────────────────┴──────────────────────────┐
  • ▼ ▼
  • [RESUSCITATION & MONITORING] [PHYSICAL TONE ASSESSMENT]
  • High-flow Oxygen (6-8 L/min mask) • Immediate Vigorous Fundal Massage
  • Two wide-bore IV lines (14G or 16G) • External or Internal Bimanual Compression
  • Rapid IV Ringer's Lactate / Saline • Insert Foley Catheter with urometer
  • Blood draw: Crossmatch 4 units, FBC, (empties bladder & tracks hourly urine)
  • bedside clotting test │
  • │ │
  • └──────────────────────────┬──────────────────────────┘
  • │
  • ▼
  • [PHARMACOLOGICAL MANAGEMENT]
  • 1. IV Oxytocin: 20 to 40 IU in 1L Saline at 40-60 drops/min (NEVER undiluted IV bolus)
  • 2. IV Tranexamic Acid (TXA): 1 g IV slowly over 10 min (give within 3 hrs of delivery)
  • 3. IM Ergometrine: 0.2 mg IM (if patient is NOT hypertensive)
  • 4. Misoprostol: 800 mcg sublingually or rectally
  • │
  • ▼
  • [DOES UTERUS CONTRACT & BLEEDING CEASE?]
  • ├─── YES ──► Continue maintenance oxytocin infusion & close monitoring
  • └─── NO ──► PROCEED TO REFRACTORY ALGORITHM
  • │
  • ▼
  • [REFRACTORY ATONY: MECHANICAL CONTROL]
  • Condom-Catheter Uterine Balloon Tamponade (UBT) inflated with 300 to 500 mL warm sterile saline
  • External Aortic Compression while preparing operating theater
  • If Trauma suspected: Speculum examination and suture cervical/vaginal lacerations
  • │
  • ▼
  • [PERSISTENT BLEEDING: SURGICAL INTERVENTION]
  • Exploratory Laparotomy: B-Lynch uterine compression sutures
  • Bilateral Uterine Artery Ligation / Internal Iliac Ligation
  • Peripartum Hysterectomy (subtotal or total) as definitive life-saving measure
  • Bimanual Uterine Compression Techniques

External Bimanual Compression: Place one hand across the posterior abdominal wall behind the fundus, pushing it forward, while the other hand presses firmly on the anterior abdominal wall over the lower segment, compressing the uterus between both hands.

Internal Bimanual Compression: Clench one gloved hand into a fist and insert it into the anterior vaginal fornix, pushing up against the anterior uterine wall. Place the other hand externally on the maternal abdominal wall behind the posterior fundus, pulling the fundus down and firmly compressing the uterine body against the vaginal fist. Maintain until the uterus contracts or balloon tamponade is placed.

Intravenous Tranexamic Acid (TXA)

Based on findings from the landmark global World Maternal Antifibrinolytic (WOMAN) trial, Tranexamic Acid (TXA) must be administered to all women with PPH within 3 hours of birth .

Dose: 1 g IV (10 mL of 100 mg/mL solution) infused slowly over 10 minutes.

If bleeding continues after 30 minutes, or restarts within 24 hours, a second 1 g IV dose is administered.

Administration after 3 hours provides no clinical benefit and is not recommended.

Uterine Balloon Tamponade (UBT / Condom-Catheter System)

In Kenya and resource-limited settings, UBT is an indispensable, minimally invasive tool:

Equipment: A sterile male latex condom tied tightly to a size 16–18 Fr Foley catheter with sterile silk or umbilical tape, connected to an IV infusion giving set and normal saline bag.

Application: Under aseptic technique, insert the condom catheter into the uterine cavity up to the fundus. Infuse 300 to 500 mL of warm sterile saline by gravity or syringe until the balloon is palpably firm and resistance is met. Tamp the vagina with sterile gauze to prevent balloon extrusion. Keep in place for 12 to 24 hours under IV antibiotic coverage, then deflate gradually over 30 minutes before removal.

Acute Uterine Inversion Management

Definition: The turning inside-out of the uterus, typically provoked by vigorous traction on the umbilical cord on a relaxed, non-contracted uterus.

Signs: Severe neurogenic and hypovolemic shock out of proportion to external bleed, sudden absence of the abdominal fundus on palpation (a deep 'cup-like' depression felt), and a large, blue-purplish vascular mass visible at the introitus or in the vagina.

Management: Immediate resuscitation, stop any oxytocin infusion (allows uterus to relax for repositioning), and perform the Johnson maneuver : Grasp the inverted fundus in the palm with fingers directed toward the posterior fornix and push the fundus steadily upward through the cervical ring toward the umbilicus. Once replaced, administer high-dose oxytocin to maintain contractility and prevent recurrence.